产品编号 |
CAS RN |
产品名称 |
产品纯度 |
原价/CNY |
优惠价/CNY |
A0736-25G |
4942-47-6 |
1-Adamantaneacetic Acid |
99.0% (T) |
1,950 |
1,658 |
A0736-5G |
4942-47-6 |
1-Adamantaneacetic Acid |
99.0% (T) |
550 |
468 |
A2691-25G |
24666-56-6 |
3-Amino-2,6-piperidinedione Hydrochloride |
98.0% (T) |
320 |
272 |
A2691-5G |
24666-56-6 |
3-Amino-2,6-piperidinedione Hydrochloride |
98.0% (T) |
100 |
85 |
A3325-1G |
756525-95-8 |
Amino-PEG2-acid tert-Butyl Ester |
92.0% (T) |
275 |
234 |
A3325-5G |
756525-95-8 |
Amino-PEG2-acid tert-Butyl Ester |
92.0% (T) |
1,280 |
1,088 |
A3412-10MG |
2230958-14-0 |
(S,R,S)-AHPC Hydrochloride |
98.0% (HPLC) |
310 |
264 |
A3412-50MG |
2230958-14-0 |
(S,R,S)-AHPC Hydrochloride |
98.0% (HPLC) |
1,450 |
1,233 |
A3455-100MG |
191732-76-0 |
5-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
98.0% (HPLC, T) |
105 |
89 |
A3455-1G |
191732-76-0 |
5-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
98.0% (HPLC, T) |
890 |
757 |
B5141-1G |
153086-78-3 |
N-(tert-Butoxycarbonyl)-2,2'-(ethylenedioxy)diethylamine |
97.0% (HPLC) |
690 |
587 |
B5141-200MG |
153086-78-3 |
N-(tert-Butoxycarbonyl)-2,2'-(ethylenedioxy)diethylamine |
97.0% (HPLC) |
190 |
162 |
B5683-1G |
127828-22-2 |
N-(tert-Butoxycarbonyl)-2-(2-aminoethoxy)ethylamine |
95.0% (GC) |
655 |
557 |
B5683-200MG |
127828-22-2 |
N-(tert-Butoxycarbonyl)-2-(2-aminoethoxy)ethylamine |
95.0% (GC) |
175 |
149 |
B6093-250MG |
1347750-75-7 |
(Boc-amino)-PEG3-C2-Carboxylic Acid |
97.0% (T, HPLC) |
695 |
591 |
B6249-250MG |
1260092-46-3 |
tert-Butyl 3-(2-Aminoethoxy)propanoate |
95.0% (GC) |
690 |
587 |
B6256-1G |
811442-84-9 |
Boc-NH-PEG4-amine |
90.0% (HPLC, T) |
6,500 |
5,525 |
B6256-200MG |
811442-84-9 |
Boc-NH-PEG4-amine |
90.0% (HPLC, T) |
1,380 |
1,173 |
B6527-1G |
2093536-12-8 |
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
98.0% (HPLC, T) |
490 |
417 |
B6527-5G |
2093536-12-8 |
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
98.0% (HPLC, T) |
1,990 |
1,692 |
B6528-100MG |
1010100-26-1 |
3-(5-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
90.0% (HPLC, qNMR) |
280 |
238 |
B6528-1G |
1010100-26-1 |
3-(5-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
90.0% (HPLC, qNMR) |
2,200 |
1,870 |
B6550-1G |
26166-92-7 |
5-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
95.0% (HPLC, T) |
290 |
247 |
B6550-5G |
26166-92-7 |
5-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
95.0% (HPLC, T) |
1,290 |
1,097 |
D5965-100MG |
1211568-27-2 |
tert-Butyl 4-(Piperidin-4-ylmethyl)piperazine-1-carboxylate |
98.0% (HPLC, T) |
190 |
162 |
D5965-500MG |
1211568-27-2 |
tert-Butyl 4-(Piperidin-4-ylmethyl)piperazine-1-carboxylate |
98.0% (HPLC, T) |
890 |
757 |
D5966-100MG |
381722-48-1 |
tert-Butyl 4-(Piperazin-1-ylmethyl)piperidine-1-carboxylate |
97.0% (HPLC, T) |
290 |
247 |
D5966-500MG |
381722-48-1 |
tert-Butyl 4-(Piperazin-1-ylmethyl)piperidine-1-carboxylate |
97.0% (HPLC, T) |
1,350 |
1,148 |
D5967-100MG |
1496997-41-1 |
2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione |
98.0% (HPLC, T) |
450 |
383 |
D5967-1G |
1496997-41-1 |
2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione |
98.0% (HPLC, T) |
1,990 |
1,692 |
D5968-1G |
835616-60-9 |
2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione |
98.0% (HPLC, T) |
390 |
332 |
D5968-5G |
835616-60-9 |
2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione |
98.0% (HPLC, T) |
1,490 |
1,267 |
D5969-1G |
835616-61-0 |
2-(2,6-Dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione |
98.0% (HPLC, T) |
690 |
587 |
D6134-1G |
5054-59-1 |
2-(2,6-Dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione |
98.0% (HPLC, T) |
490 |
417 |
D6134-5G |
5054-59-1 |
2-(2,6-Dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione |
98.0% (HPLC, T) |
1,490 |
1,267 |
D6178-1G |
64567-60-8 |
2-(2,6-Dioxopiperidin-3-yl)-5-hydroxyisoindoline-1,3-dione |
95.0% (HPLC, T) |
690 |
587 |
D6178-5G |
64567-60-8 |
2-(2,6-Dioxopiperidin-3-yl)-5-hydroxyisoindoline-1,3-dione |
95.0% (HPLC, T) |
2,890 |
2,457 |
D6191-500MG |
1216805-11-6 |
2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindoline-5-carboxylic Acid |
98.0% (HPLC, T) |
690 |
587 |
D6235-100MG |
1547163-38-1 |
2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindoline-4-carboxylic Acid |
98.0% (HPLC, qNMR) |
690 |
587 |
D6235-1G |
1547163-38-1 |
2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindoline-4-carboxylic Acid |
98.0% (HPLC, qNMR) |
3,290 |
2,797 |
P2074-100MG |
19171-19-8 |
Pomalidomide |
98.0% (HPLC) |
290 |
247 |
P2074-25MG |
19171-19-8 |
Pomalidomide |
98.0% (HPLC) |
165 |
140 |
T4212-100MG |
|
TCO-NPC equatorial isomer |
98.0% (HPLC, qNMR) |
990 |
842 |
T4213-100MG |
|
TCO-NPC axial isomer |
98.0% (HPLC, qNMR) |
1,490 |
1,267 |
T4218-100MG |
|
TCO*-NPC axial isomer |
98.0% (HPLC, qNMR) |
1,490 |
1,267 |
T4219-100MG |
|
TCO*-NPC equatorial isomer |
98.0% (HPLC, qNMR) |
1,490 |
1,267 |
T4233-25MG |
|
TCO-PEG3-amine axial isomer |
90.0% (HPLC, qNMR) |
1,990 |
1,692 |
T4234-25MG |
|
TCO-PEG3-amine equatorial isomer |
90.0% (HPLC, qNMR) |
1,390 |
1,182 |
T4238-25MG |
|
TCO-PEG3-DBCO axial isomer |
85.0% (qNMR) |
1,990 |
1,692 |
T4239-25MG |
|
TCO-PEG3-DBCO equatorial isomer |
80.0% (qNMR) |
4,200 |
3,570 |
T4219-100MG |
|
TCO*-NPC equatorial isomer |
98.0% (HPLC, qNMR) |
1,490 |
1,267 |
T4233-25MG |
|
TCO-PEG3-amine axial isomer |
90.0% (HPLC, qNMR) |
1,990 |
1,692 |
T4234-25MG |
|
TCO-PEG3-amine equatorial isomer |
90.0% (HPLC, qNMR) |
1,390 |
1,182 |
T4238-25MG |
|
TCO-PEG3-DBCO axial isomer |
85.0% (qNMR) |
1,990 |
1,692 |
T4239-25MG |
|
TCO-PEG3-DBCO equatorial isomer |
80.0% (qNMR) |
4,200 |
3,570 |